FDA panel to review NicOx's anti-inflammatory naproxcinod
08 March 2010
Nancy Faigen
A joint meeting of the US FDA's arthritis drugs advisory committee and the drug safety and risk management advisory committee has been scheduled for May 12th to review
NicOx's anti-inflammatory agent naproxcinod for the treatment of osteoarthritis.
Naproxcinod, NicOx's lead investigational compound,...
Please Login to read the full article.
08 March 2010
Nancy Faigen
Naproxcinod, NicOx's lead investigational compound,...
Please Login to read the full article.
RELATED CONTENT
COMMENT
Other Informa Comment
EVENTS
26 February 2012
Vancouver Convention Centre | Vancouver, BC, Canada
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
JOB OF THE WEEK
Promote your vacancy here
